IRME IR-Med Inc. Forecast, Technical & Fundamental Analysis

IRME's Stochastic Oscillator is staying in overbought zone for 5 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IRME moved out of overbought territory on December 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 25, 2025. You may want to consider a long position or call options on IRME as a result. In of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IRME just turned positive on November 28, 2025. Looking at past instances where IRME's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

IRME moved above its 50-day moving average on November 20, 2025 date and that indicates a change from a downward trend to an upward trend.

IRME may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 111 cases where IRME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IRME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IRME's P/B Ratio (10000.000) is very high in comparison to the industry average of (63.245). P/E Ratio (0.000) is within average values for comparable stocks, (37.125). IRME's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.644). IRME has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.000) is also within normal values, averaging (35.253).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRME’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.